1. Excellergy Presents New Data at 2026 AAAAI Annual Meeting Demonstrating Rapid
Reporting captured by itnewsonline.com on 2026-02-27 described "Excellergy Presents New Data at 2026 AAAAI Annual Meeting Demonstrating Rapid and Sustained Allergic Effector Cell Control and Announces First Subjects Dosed in Phase 1 DISARM Trial" as a live risk signal in health science integrity and product safety. The...